WATSON 3209 (Rivastigmine Tartrate 3 mg)
Pill with imprint WATSON 3209 is Yellow, Capsule-shape and has been identified as Rivastigmine Tartrate 3 mg. It is supplied by Watson Pharmaceuticals.
Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 3209
Rivastigmine Tartrate
- Imprint
- WATSON 3209
- Strength
- 3 mg
- Color
- Yellow
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- Inactive Ingredients
-
silicon dioxide, magnesium stearate, microcrystalline cellulose, gelatin, titanium dioxide, ferric oxide yellow, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, indigotindisulfonate sodium, FD&C Red No. 40, shellac, propylene glycol
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-3209 | Watson Pharmaceuticals, Inc. |
| 63739-0577 | McKesson Packaging Services |
More about rivastigmine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- 29 Reviews
- Drug class: cholinesterase inhibitors
Consumer resources
- Rivastigmine
- Rivastigmine transdermal
- Rivastigmine (Advanced Reading)
- Rivastigmine Transdermal (Advanced Reading)
- Rivastigmine Capsules
- ... +2 more
Other brands: Exelon
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
